Lilly Right-Sizes Sales Force As It Pushes Its Pipeline Forward
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharma is cutting costs as it continues to reel from revenues lost to generic competition. Meanwhile, it moves its late-stage pipeline forward in hopes of filling the gaps.